{"schema_version":"secwatch.filing_event.v1","accession":"0001438133-22-000220","form_type":"8-K","ticker":"TNDM","cik":"0001438133","company_name":"TANDEM DIABETES CARE INC","filed_at":"2022-11-02T23:59:59+00:00","discovered_at":"2026-05-14T18:03:50.662601+00:00","generated_at":"2026-06-22T13:19:20.126023+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"low","headline":"Tandem Diabetes reports Q3 2022 results; financial details unavailable from filing excerpt","bullets":["Tandem Diabetes issued a press release on November 2, 2022, covering Q3 2022 financial performance.","No specific financial figures (revenue, EPS, guidance) were extractable from the provided filing text.","Investors should refer to the full press release for detailed results and analysis."],"urls":{"canonical":"https://secwatch.observer/filing/0001438133-22-000220","json":"https://secwatch.observer/filing/0001438133-22-000220.json","markdown":"https://secwatch.observer/filing/0001438133-22-000220.md","text":"https://secwatch.observer/filing/0001438133-22-000220.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1438133/000143813322000220/0001438133-22-000220-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1438133/000143813322000220/tndm-20221102.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-22T13:19:20.126023+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}